|
1
|
Kelsen DP, Ginsberg R, Pajak TF, Sheahan
DG, Gunderson L, Mortimer J, Estes N, Haller DG, Ajani J, Kocha W,
et al: Chemotherapy followed by surgery compared with surgery alone
for localized esophageal cancer. N Engl J Med. 339:1979–1984. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Medical Research Council Oesophageal
Cancer Working Group: Surgical resection with or without
preoperative chemotherapy in oesophageal cancer: A randomised
controlled trial. Lancet. 359:1727–1733. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
van Hagen P, Hulshof MC, van Lanschot JJ,
Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ,
Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, et al: Preoperative
chemoradiotherapy for esophageal or junctional cancer. N Engl J
Med. 366:2074–2084. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Davies AR, Gossage JA, Zylstra J, Mattsson
F, Lagergren J, Maisey N, Smyth EC, Cunningham D, Allum WH and
Mason RC: Tumor stage after neoadjuvant chemotherapy determines
survival after surgery for adenocarcinoma of the esophagus and
esophagogastric junction. J Clin Oncol. 32:2983–2990. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Abate-Shen C: Deregulated homeobox gene
expression in cancer: Cause or consequence? Nat Rev Cancer.
2:777–785. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Beck F: Homeobox genes in gut development.
Gut. 51:450–454. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Grier DG, Thompson A, Kwasniewska A,
McGonigle GJ, Halliday HL and Lappin TR: The pathophysiology of HOX
genes and their role in cancer. J Pathol. 205:154–171. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen KN, Gu ZD, Ke Y, Li JY, Shi XT and Xu
GW: Expression of 11 HOX genes is deregulated in esophageal
squamous cell carcinoma. Clin Cancer Res. 11:1044–1049.
2005.PubMed/NCBI
|
|
9
|
Gu ZD, Shen LY, Wang H, Chen XM, Li Y,
Ning T and Chen KN: HOXA13 promotes cancer cell growth and predicts
poor survival of patients with esophageal squamous cell carcinoma.
Cancer Res. 69:4969–4973. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Du YB, Dong B, Shen LY, Yan WP, Dai L,
Xiong HC, Liang Z, Kang XZ, Qin B and Chen KN: The survival
predictive significance of HOXC6 and HOXC8 in esophageal squamous
cell carcinoma. J Surg Res. 188:442–450. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li H, Shen LY, Yan WP, Dong B, Kang XZ,
Dai L, Yang YB, Fu H, Yang HL, Zhou HT, et al: Deregulated HOXB7
expression predicts poor prognosis of patients with esophageal
squamous cell carcinoma and regulates cancer cell proliferation in
vitro and in vivo. PLoS One. 10:e01305512015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shen LY, Wang H, Dong B, Yan WP, Lin Y,
Shi Q and Chen KN: Possible prediction of the response of
esophageal squamous cell carcinoma to neoadjuvant chemotherapy
based on gene expression profiling. Oncotarget. 7:4531–4541. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mandard AM, Dalibard F, Mandard JC, Marnay
J, Henry-Amar M, Petiot JF, Roussel A, Jacob JH, Segol P, Samama G,
et al: Pathologic assessment of tumor regression after preoperative
chemoradiotherapy of esophageal carcinoma. Clinicopathologic
correlations. Cancer. 73:26801994. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hamada S, Satoh K, Hirota M, Kanno A,
Umino J, Ito H, Masamune A, Kikuta K, Kume K and Shimosegawa T: The
homeobox gene MSX2 determines chemosensitivity of pancreatic cancer
cells via the regulation of transporter gene ABCG2. J Cell Physiol.
227:729–738. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xiao F, Bai Y, Chen Z, Li Y, Luo L, Huang
J, Yang J, Liao H and Guo L: Downregulation of HOXA1 gene affects
small cell lung cancer cell survival and chemoresistance under the
regulation of miR-100. Eur J Cancer. 50:1541–1554. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu W, Deng L, Song Y and Redell M: DOT1L
inhibition sensitizes MLL-rearranged AML to chemotherapy. PLoS One.
9:e982702014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li N, Jia X, Wang J, Li Y and Xie S:
Knockdown of homeobox A5 by small hairpin RNA inhibits
proliferation and enhances cytarabine chemosensitivity of acute
myeloid leukemia cells. Mol Med Rep. 12:6861–6866. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gaspar N, Marshall L, Perryman L, Bax DA,
Little SE, Viana-Pereira M, Sharp SY, Vassal G, Pearson AD, Reis
RM, et al: MGMT-independent temozolomide resistance in pediatric
glioblastoma cells associated with a PI3-kinase-mediated HOX/stem
cell gene signature. Cancer Res. 70:9243–9252. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tang CH, Parham C, Shocron E, McMahon G
and Patel N: Picoplatin overcomes resistance to cell toxicity in
small-cell lung cancer cells previously treated with cisplatin and
carboplatin. Cancer Chemother Pharmacol. 67:1389–1400. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen H, Zhang H, Lee J, Liang X, Wu X, Zhu
T, Lo PK, Zhang X and Sukumar S: HOXA5 acts directly downstream of
retinoic acid receptor beta and contributes to retinoic
acid-induced apoptosis and growth inhibition. Cancer Res.
67:8007–8013. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sugimoto Y, Nakamura S, Okinaka K, Hirano
I, Ono T, Shigeno K, Shinjo K and Ohnishi K: HOXA10 expression
induced by Abl kinase inhibitors enhanced apoptosis through PI3K
pathway in CML cells. Leuk Res. 32:962–971. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shah N, Jin K, Cruz LA, Park S, Sadik H,
Cho S, Goswami CP, Nakshatri H, Gupta R, Chang HY, et al: HOXB13
mediates tamoxifen resistance and invasiveness in human breast
cancer by suppressing ERα and inducing IL-6 expression. Cancer Res.
73:5449–5458. 2013. View Article : Google Scholar : PubMed/NCBI
|
